INTRODUCTION
The secondary pool of genomic information provided
by bacteria, fungi, viruses and other microorganisms
that constitute the totality of an organism’s resident
microbial community create what clinicians and investigators
now refer to as a “microbiome.â€1,2 The advent of microbiome
studies via the utility of high throughput genomic sequencing
has uncovered a revolutionary perspective regarding the
investigation of disease pathogenesis—rather than focusing
on invading pathogens as the sole etiological agents of certain
diseases, shifts in an individual’s microbial community profile
are now being evaluated as associated culprits in disease causation.
Thus, appreciation of the unique interaction between
inhabitant microbial flora, the host’s endogenous genetic
factors and exogenous environmental elements reveal that
maintenance of this complex symbiotic relationship between
human host and resident microbes is essential for facilitating
tissue homeostasis. Of particular interest, studies have associated
alterations in the hyperdiverse microbial communities
that colonize human skin with the pathogenesis of commonly
diagnosed dermatological diseases.3-5 This mini-review will
survey and summarize some of the recent studies conducted
with similar high throughput technologies that suggest modifications
in the ecology of skin microorganisms play a critical
role in the disease process for atopic dermatitis and psoriasis.
Skin Microbiome
The human microbiome is invariably established shortly after
birth due to the rapid colonization of microorganisms that outnumber
host cells 10-fold.6 The resulting microbial ecosystem exhibits stable resident populations, found endogenously and
superficially, as well as transient populations.7 The total composition
of resident commensal organisms is contingent upon
key biological factors including temperature, sebum content,
antibiotic/probiotic use, humidity, and pH.8,9 Skin possesses
the ability to shape the aggregate microbiome by facilitating
the colonization of commensal organisms while effectively
warding off pathogenic organisms through mechanisms like
desquamation and the release of inducible and constitutively
expressed antimicrobial peptides.10 For years, microbial
dysbiosis has been recognized as a way for typically benign
residential organisms to convert into pathogenic agents.6,11 The
harsh, desiccated environment of the skin also acts to inhibit
the proliferation of pathogenic invaders of the skin.10
Rather than characterizing skin microflora as a monolithic entity,
skin microbiome studies have elucidated the understanding
that distinct anatomical locations harbor unique populations
of microorganisms that function in both health and disease
states.1,2,8 Furthermore, differing concentration of adnexal
structures such as hair follicles, sebaceous, eccrine, and apocrine
glands may very well contribute to the microbiome’s
phylogenetic hyperdiversity.12 Traditional methods of culturing
that often identified Staphylococcus, Corynebacterium,
Propionibacterium, Streptococcus and Pseudomonas as key
constituents of skin microbiota have been expounded upon
with the standardization of 16S rRNA gene sequencing.8,9 Evidence
now suggests that human skin includes upwards of 100
phylotypes that belong to 6 divisions of bacteria.10,13 Regions of